Stewart J Tepper

7PUBLICATIONS
27CO-AUTHORS
Traditional Chinese medicine and treatmentsEpidemiological methodsPharmacogenomicsFood properties (incl. characteristics and health benefits)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial.

|Jul 28, 2025
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.

Stewart J Tepper, Aaron Jenkins, Carl Henriksen

|Jun 10, 2025
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials.

Stewart J Tepper, Jelena M Pavlovic, Shengyuan Yu

|Jan 24, 2025
Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur.

Stewart J Tepper, Katharine Tepper

|Dec 12, 2024
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.

Stewart J Tepper, Merle L Diamond, Joe Hirman

Pageof 2

Frequent Collaborators

2 joint publications

Lucy Abraham

2 joint publications

Richard B Lipton

2 joint publications

Feng Dai

2 joint publications

Aaron Jenkins